For citations:
Korotaeva T.V., Mazurov V.I., Lila A.M., Gaydukova I.Z., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Zinkina-Orikhan A.V., Sevastyanova Yu.A., Eremeeva A.V. Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study. Rheumatology Science and Practice. 2021;59(1):47-55. (In Russ.) https://doi.org/10.47360/1995-4484-2021-47-55
Email this article 